OTC Markets OTCPK - Delayed Quote USD

(EBRCZ)

0.5481
0.0000
(0.00%)
At close: May 7 at 4:00:00 PM EDT
Loading Chart for EBRCZ
  • Previous Close 0.0000
  • Open --
  • Bid --
  • Ask --
  • Day's Range --
  • 52 Week Range 0.5481 - 0.5481
  • Volume --
  • Avg. Volume 0
  • Market Cap (intraday) 204.384M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1200
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. The company offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of wires or leads; and SOLVE-CRT, an investigational device exemption. The company was incorporated in 2003 and is headquartered in Sunnyvale, California.

www.ebrsystemsinc.com

89

Full Time Employees

December 31

Fiscal Year Ends

Recent News: EBRCZ

View More

Performance Overview: EBRCZ

Trailing total returns as of 5/17/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

EBRCZ
0.00%
MSCI WORLD (^990100-USD-STRD)
4.19%

1-Year Return

EBRCZ
0.00%
MSCI WORLD (^990100-USD-STRD)
11.25%

3-Year Return

EBRCZ
70.75%
MSCI WORLD (^990100-USD-STRD)
40.65%

5-Year Return

EBRCZ
70.75%
MSCI WORLD (^990100-USD-STRD)
0.00%

Compare To: EBRCZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EBRCZ

View More

Valuation Measures

Annual
As of 5/16/2025
  • Market Cap

    265.96M

  • Enterprise Value

    272.77M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -34.42%

  • Return on Equity (ttm)

    -229.02%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -42.2M

  • Diluted EPS (ttm)

    -0.1200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    47.87M

  • Total Debt/Equity (mrq)

    375.56%

  • Levered Free Cash Flow (ttm)

    -28.21M

Research Analysis: EBRCZ

View More

Company Insights: EBRCZ

Research Reports: EBRCZ

View More